Skip to content

Foundation Fighting Blindness Retinal Degeneration Fund, Director at Opus Genetics, sold IRD on Sep 30, 2026

Data as of Oct 16

▼ SELL$2.8M556,000 shares at $4.96Foundation Fighting Blindness Retinal Degeneration Fund DirectorIRD Opus Genetics, Inc.
Watch IRD
Traded
Sep 30, 2026
Disclosed
Oct 2, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Foundation Fighting Blindness Retinal Degeneration Fund, Director at Opus Genetics, sold IRD on Sep 30, 2026TRADEDDISCLOSED
IRDSimilar stocks (XLV — its sector index fund), rebased to IRD's price on the disclosure day
IRD since disclosure
−16.2%
after the sale
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund

Change in closing price from Oct 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLFoundation Fighting Blindness, Inc. DirectorIRD Opus Genetics, Inc.$2.8Mdisclosed Oct 2 · filed 2 days after the trade

See every trade on IRD →